Chengdu Bright Eye Hospital Co., Ltd. (301239.SZ)
- Previous Close
45.74 - Open
46.33 - Bid 48.25 x --
- Ask 48.33 x --
- Day's Range
45.91 - 49.67 - 52 Week Range
45.05 - 135.49 - Volume
3,082,200 - Avg. Volume
2,551,632 - Market Cap (intraday)
7.227B - Beta (5Y Monthly) --
- PE Ratio (TTM)
59.63 - EPS (TTM)
0.81 - Earnings Date --
- Forward Dividend & Yield 0.10 (0.22%)
- Ex-Dividend Date Jul 17, 2023
- 1y Target Est
113.29
Chengdu Bright Eye Hospital Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, and medical optometry for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthalmology, fundus disease, glaucoma, strabismus and pediatric ophthalmology, lacrimal duct, cornea orbital disease, eye trauma, medical optometry, and other general ophthalmology diagnosis and treatment items. The company is headquartered in Shanghai, China.
www.purui.cn4,918
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 301239.SZ
Performance Overview: 301239.SZ
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 301239.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 301239.SZ
Valuation Measures
Market Cap
6.84B
Enterprise Value
7.99B
Trailing P/E
56.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.52
Price/Book (mrq)
3.00
Enterprise Value/Revenue
2.91
Enterprise Value/EBITDA
27.71
Financial Highlights
Profitability and Income Statement
Profit Margin
4.46%
Return on Assets (ttm)
4.30%
Return on Equity (ttm)
5.78%
Revenue (ttm)
2.74B
Net Income Avi to Common (ttm)
122.45M
Diluted EPS (ttm)
0.81
Balance Sheet and Cash Flow
Total Cash (mrq)
748.42M
Total Debt/Equity (mrq)
82.18%
Levered Free Cash Flow (ttm)
75.22M
Research Analysis: 301239.SZ
Company Insights: 301239.SZ
301239.SZ does not have Company Insights